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decreased from 139 to 137 mmol/l on day 2, and then
increased to 140 mmol/l on day 7. This slow increase in
serum Na concentration did not cause central pontine
myelinolysis.
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About the association between
high alkaline phosphatase
and risk of death and
hospitalization in dialysis
patients
Kidney International (2009) 75, 1114; doi:10.1038/ki.2008.673
To the Editor: We have been very interested by the
epidemiological link between high alkaline phosphatase and
the risk of death and hospitalization in the Dialysis Outcomes
and Practice Patterns Study cohort.1 It is interesting that the
authors pointed out that this association was independent of
calcium, phosphorus, and parathyroid hormone levels, as
well as active vitamin D use. However, no mention was made
about their 25 OH vitamin D serum levels, which may vary
widely according to country latitude, as well as country-
specific reimbursement policy, for intravenous or oral
administration of active or plain vitamin D.
Knowledge of 25 OH vitamin D status is important, as
Wolf et al.2 have pointed out that low 25 OH vitamin D in
incident hemodialysis patients was a strong predictor of early
all-cause mortality.
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Regarding our article on the Dialysis Outcomes and
Practice Patterns Study (DOPPS),1 the comments by
Baakrim, Shahapuni, Rouached, and Fournier on mortality
risk by serum levels of 25 OH vitamin D2 provide an
important perspective to the dialysis practice. In DOPPS 4,
we inquired about the practice of measuring 25 OH
vitamin D in the sample of international dialysis facilities.
Unfortunately, only 16% of dialysis facility medical
directors indicated that it is being measured routinely
(7% quarterly, 6% biannually, and 3% annually). Any
measurement varied markedly by country, ranging from
0% in the sample of facilities in Australia, New Zealand,
Canada, Sweden, and the United Kingdom to 54% of
facilities in Belgium, 60% in France, and 67% in Germany.
Thus, their comment points to a current area of limited
attention and an opportunity to study the effect of targeted
treatment based on prospective measurement of 25 OH
vitamin D.
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Factors aside from Helicobacter
pylori play an important role in
the occurrence of peptic ulcer
in dialysis patients
Kidney International (2009) 75, 1114–1115; doi:10.1038/ki.2009.26
To the Editor: We read with interest the article entitled
‘Prevalence of Helicobacter pylori in long-term hemodialysis
patients’ by Sugimoto et al.1 In this study, Sugimoto et al.
reported that compared to patients with normal renal
function, the dialysis patients had lower prevalence of
H. pylori, which significantly decreased as the duration of
dialysis increased, and they still had significant peptic ulcer
disease.1 In a 5-year follow-up study of a community
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